Papa Johns shuts nearly 50 stores, cuts 7% of corporate staff as competition bites

What happened

Papa Johns has closed nearly 50 underperforming locations across 17 states and laid off 7% of its corporate workforce, intensifying its restructuring amid a fiercely competitive pizza market. The closures and layoffs, reported by the New York Post, follow a year of negative North America comparable sales and a failed private-equity bid in late 2025. The company's own filings show domestic comps fell 2.7% in Q3 2025 and 4% in full-year 2024, with customers trading down to smaller, cheaper orders. Management had already flagged $25 million in non-marketing cost savings for 2026–2027 and an accelerated refranchising plan, but the latest moves suggest the company is further trimming its own store base and overhead to stabilize margins. While the store rationalization could improve unit-level economics, it also signals that the core U.S. business continues to struggle, with system-wide sales under pressure from value-oriented rivals and shifting consumer preferences.

Implication

This development is a stark confirmation that Papa Johns' North America turnaround is still losing ground. The shuttering of nearly 50 franchises and the corporate layoffs are not a one-time pruning but rather a recognition that the brand's market position has eroded further. Investors should view this as increasing the probability of the bear case scenario described in our prior analysis, where EBITDA stagnates near $180 million and net leverage drifts toward 5.0x. The stock's current valuation at ~9.4x EV/EBITDA leaves little room for error, and without clear evidence that domestic comparable sales can recover to at least flat, the risk of permanent capital loss remains elevated. We recommend maintaining a WAIT stance and trimming any existing position on strength unless the company can demonstrate two consecutive quarters of positive North America comps and an EBITDA inflection.

Thesis delta

The thesis shifts incrementally toward the bear case: the pace of store closures and layoffs indicates that North America comps are not stabilizing as hoped, raising the risk that the cost savings and refranchising plan may not be enough to offset volume declines. The previously assumed base case of modest EBITDA recovery by 2027 now appears less likely, as the scale of restructuring suggests deeper demand issues. We lower our conviction and recommend a more patient entry at lower prices, near $30, where the margin of safety would be more adequate.